Atria Investments »

Centessa Pharmaceuticals shares owned by Atria Investments

Quarter-by-quarter ownership of Centessa Pharmaceuticals (CNTA) shares owned by Atria Investments from 13F filings

Historical chart of Atria Investments investment in Centessa Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Centessa Pharmaceuticals held by Atria Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Centessa Pharmaceuticals by Atria Investments

Quarter filed Position value Share count Share price at filing
2024-09-30 $274k 17k 15.99
2024-06-30 $145k 16k 9.03

More positions owned by Atria Investments

Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Unified Ser Tr Oneascent Core P (OACP)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Apple (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Unified Ser Tr Oneascent Intl (OAIM)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Growth Etf (VUG)
Meta Platforms Cl A (META)
Ishares Tr Core Total Usd (IUSB)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Unified Ser Tr Oneascent Large (OALC)

View all positions for Atria Investments

Top funds holding Centessa Pharmaceuticals

Medicxi Ventures Management
General Atlantic
Perceptive Advisors
First Light Asset Management
T. Rowe Price Associates
Adage Capital Partners GP
Vida Ventures Advisors
T. Rowe Price Investment Management
Siren
EcoR1 Capital
FMR
TCG Crossover Management
Farallon Capital Management
Point72 Asset Management
Cormorant Asset Management

View all funds holding Centessa Pharmaceuticals